QuidelOrtho Corp (QDEL)
43.77
+0.32
(+0.74%)
USD |
NASDAQ |
Oct 04, 16:00
43.79
+0.02
(+0.05%)
After-Hours: 20:00
QuidelOrtho SG&A Expense (Annual): 763.20M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 763.20M |
December 31, 2022 | 621.00M |
December 31, 2021 | 239.60M |
December 31, 2020 | 200.54M |
December 31, 2019 | 163.87M |
December 31, 2018 | 153.94M |
December 31, 2017 | 96.44M |
December 31, 2016 | 76.79M |
December 31, 2015 | 77.46M |
December 31, 2014 | 68.89M |
December 31, 2013 | 61.32M |
December 31, 2012 | 50.12M |
December 31, 2011 | 48.55M |
December 31, 2010 | 43.32M |
December 31, 2009 | 40.13M |
December 31, 2008 | 33.68M |
December 31, 2007 | 31.66M |
December 31, 2006 | 29.74M |
December 31, 2005 | 29.18M |
December 31, 2004 | 28.84M |
December 31, 2003 | 25.98M |
Date | Value |
---|---|
December 31, 2002 | 23.49M |
December 31, 2001 | 24.62M |
December 31, 2000 | 25.19M |
December 31, 1999 | 16.30M |
March 31, 1999 | 15.80M |
March 31, 1998 | 15.70M |
March 31, 1997 | 14.20M |
March 31, 1996 | 18.10M |
March 31, 1995 | 18.90M |
March 31, 1994 | 16.00M |
March 31, 1993 | 13.20M |
March 31, 1992 | 11.70M |
March 31, 1991 | 17.50M |
March 31, 1990 | 4.70M |
March 31, 1989 | 5.60M |
March 31, 1988 | 5.90M |
March 31, 1987 | 7.20M |
March 31, 1986 | 5.50M |
March 31, 1985 | 5.40M |
March 31, 1984 | 4.70M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
163.87M
Minimum
2019
763.20M
Maximum
2023
397.64M
Average
239.60M
Median
2021
SG&A Expense (Annual) Benchmarks
Abbott Laboratories | 10.95B |
Becton Dickinson & Co | 4.719B |
Perspective Therapeutics Inc | 21.06M |
Xtant Medical Holdings Inc | 64.29M |
Catheter Precision Inc | 17.12M |